Subjects in the study were monitored using the LUX-Dx insertable cardiac monitor system to detect arrhythmia recurrence.

These foci are commonly in the superior pulmonary veins; this is an important factor in the electrophysiologic approach to atrial fibrillation, known as pulmonary vein isolation. Less commonly ...

For patients newly diagnosed with atrial fibrillation (AF) during hospitalization for other causes, most are not dispensed ...

Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month primary endpoint results from the second phase of ...

Atrial fibrillation is the most common cardiac arrhythmia that is encountered in clinical practice, with some 4.5% of the general population affected in the United States. It has been nearly 30 ...

One of AI’s most immediate impacts is in screening and identifying patients who may have asymptomatic or paroxysmal AF, those ...

in combination with conventional pulmonary vein isolation (PVI), resulted in significantly improved outcomes for patients with persistent atrial fibrillation compared to PVI alone.

technology for the treatment of atrial fibrillation. CardioFocus will kick off the week at the Stanford Biodesign New Arrhythmia Technologies Retreat on Wednesday, April 23, at The Westin San Diego.

Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, today announced the initiation of the ...